Targeted drug delivery system refers to the method that selectively transports drugs to targeted tissues, organs, and cells through a variety of drugs carrier. Though tens of thousands of drug delivery systems have been developed, the effect has been minimal. This is because hundreds of proteins in the body stick to the drug delivery system (protein corona phenomenon). Because of this phenomenon, even when the drug reaches a target such as a cancer cell, the treatment efficiency is very low, and other side effects have been observed, which may cause toxic side effects.
"It was reported that it is possible to alleviate the impact of protein corona on target drug delivery through the formation of protective shield, made up of well-structured special proteins that are highly stable and do not interact with each other," says the co-senior author. "The new technology is much like the strategy where you take control of your enemies, using enemies."
In this work published in Nature Communications, the research team introduced the protein corona shield (PCS) concept for an efficient target drug delivery system. Using recombinant DNA technology, the research team has created recombinant fusion proteins with the enhanced physical stability and cancer-selective targeting ability. This fusion protein, then, was used as a shield to encapsulate the surface of nanoparticle drug carriers, thus constructing PCS nanoparticles (PCSNs).
In principle, nanoparticle drug carriers with a target ligand lose their targeting ability on being coated by blood proteins in a biological environment. However, the new PCS system can inhibit blood protein adsorption to maintain the targeting ability and avoid unwanted clearance by the mononuclear phagocyte system.
To understand the interactions between PCSNs and external biological components, the research team has created an environment similar to human biological systems. This has been analyzed via computer simulation. The results showed about 10 times greater therapeutic efficacy in preventing the invasion of unwanted external proteins.
They also examined the effect of drug delivery using immune cells and cancer cells. The PCS drug delivery system could kill cancer cells without being caught by immune cells, even after long-term exposure to biological environments. In mouse models of cancer, the team found that the PCSN exhibit lower toxicity, as well as excellent tumor-targeting ability.
"Aside from treating cancer, our findings can also be applied to a variety of fields, such as the diagnosis and treatment of various diseases, as well as the heat-optical therapy," says the senior author. "We plan to introduce a platform that will perform various roles while differently designing recombinant proteins in the future."
https://news.unist.ac.kr/nanoparticle-breakthrough-in-the-fight-against-cancer/
https://www.nature.com/articles/s41467-018-06979-4
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fcloaking-nanoparticles&filter=22
Latest News
Early signs of Parkinson's disease seen in general health parameters
Structural changes in G6PD causes common blood disorder
Reversing cognitive decline in ageing by restoring immune cell metabolism
Why remdesivir does not fully stop the coronavirus
Trash removal during deep sleep!
Other Top Stories
How fish brain responds to beta-amyloid challenge?
Delivering synthetic nanomaterial to prevent the scarring after heart attack
Tooth enamel damage from mutation of a gene
Brain's emotional center contributes to eating for pleasure!
Disrupting protein-RNA interaction prevents neurotoxicity in ALS
Protocols
Dual-Angle Protocol for Doppler Optical Coherence Tomography to Improve Retinal Blood Flow Measur…
Detection of protein SUMOylation in vivo
In vivo analysis of protein sumoylation induced by a viral protein: Detection of HCMV pp71-induce…
Determination of SUMOylation sites
miR-Selection 3'UTR Target Selection Kit
Publications
A neurophysiological model of speech production deficits in fragile X syndrome
Reduced peroxisomal import triggers peroxisomal retrograde signaling
Shaping Neuronal Fate: Functional Heterogeneity of Direct Microglia-Neuron Interactions
Diabetes, obesity, metabolism and SARS-CoV-2 infection: The end of the beginning
Lymph nodes are innervated by a unique population of sensory neurons with immunomodulatory potential
Presentations
Homeostasis
PLANT MITOCHONDRIAL BIOLOGY
Photosynthesis
Endocrine Disorders
THE PITUITARY GLAND
Posters
ACMT 2020 Annual Scientific Meeting Abstracts - New York, NY
Abstracts from the 2020 Annual Scientific Meeting of the British and Irish Hypertension Society (…
ACNP 58th Annual Meeting: Poster Session III
ACNP 58th Annual Meeting: Poster Session II
ACNP 58th Annual Meeting: Poster Session I